Thursday, March 15, 2018 7:39:37 AM
Mark Schaftlein
60 Chief Executive Officer, Chief Financial Officer and Director
Pam Pennoyer
56 Shareholder (owning approx. 18.3% of Company’s outstanding common shares 31,062,500 and 25% of the Series 2014A Preferred Shares 250)
Ronald Henthorn
Shareholder (owning approx. 18.3% of Company’s outstanding common shares 31,062,500 and 25% of the Series 2014A Preferred Shares 250)
Capital Consulting, Inc.
Shareholder (owning approx. 7.0% of Company’s outstanding common shares and 50% of the Series 2014 Preferred Shares 500). This is a corporation controlled by Mark Schaftlein, CEO and Director.
On February 1, 2018, Murray Fleming, a former director of the Company, assigned his 250 shares of 2014A preferred stock to Capital Consulting Inc.
RYOX Corporation
Shareholder (owning approx. 7.0% of Company’s outstanding common shares. This is a corporation controlled by Murray Fleming, former Director.
Nacel Energy Corporation -- Shareholder (owning approx. 6.2% of Company’s outstanding common shares).
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM